Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Contrast Enhanced Ultrasound in Lymphatic Imaging
2024-519077-19-01Phase 3Authorised
- Sponsor
- Kuopio University Hospital
- Start
- Dec 2024
- Modality
- Acoustic/Optical: Sonoporation, laser photoporation → Physical Methods → Gene Addition/Replacement → Gene Therapies, Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of sonazoid in breast cancer, sponsored by Kuopio University Hospital. Primary endpoint: Visualization of superficial lymphatic vessels. Planned start Dec 2024; status: authorised.
02
Drugs
sonazoid
03
Conditions
breast cancer
Beyond the preview
Go deeper on 2024-519077-19-01.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-519077-19-01.